서울시의사회, “만관제, 긍정과 염려 혼재 속 적극 참여 권장 입장”

글 내용 전체보기

[2018결산] ‘제약산업, 한발 더 국민속으로’

글 내용 전체보기

경남제약 상장폐지 결정, 일파만파

글 내용 전체보기

혈액 부족에 직면한 병원, 어떻게 대응해야 할까?

글 내용 전체보기

화이자, ‘프리베나13’ 뛰어넘을 20가 백신 향한 항해 시작

글 내용 전체보기

5 Steps to Achieving Your Goals at Work, From a Career Expert

글 내용 전체보기

Study: The More Popular the Health-Related YouTube Video, the More Likely It Is to Be Inaccurate

글 내용 전체보기

FDA Scraps 2013 Generic Drug Label Proposal That Could Have Exposed Manufacturers to Lawsuits

글 내용 전체보기

In Deal Totaling $3.7 Billion, Merck Buys Animal Health Company Antelliq

글 내용 전체보기

XenoTherapeutics Plans to Initiate Clinical Trials for a Pig-Skin Burn Treatment

글 내용 전체보기

December 14 Research Roundup: Lonesome George’s Genome, Alzheimer’s and Prostate Cancer Tests and

글 내용 전체보기

Radical Prostate Surgery Provides 3 Extra Years of Life Compared to Watchful Waiting

글 내용 전체보기

Axovant Licenses Two Gene Therapies Aimed at Tay-Sachs and Sandhoff Disease

글 내용 전체보기

Amgen Terminates $540 Million Developmental Deal with Advaxis

글 내용 전체보기

A is for Amplify: CRISPRa Used to Treat Obesity Without Editing the Genome

글 내용 전체보기

Prestige BioPharma Partners with Cipla Ltd to Market Key Cancer Biosimilar

글 내용 전체보기

Orchard Therapeutics and SIRION Biotech Announce Licensing Agreement to Enhance Gene Therapy Manufacturing Efficiency

글 내용 전체보기

Merck shells out $2.4B for cutting-edge animal tech company Antelliq

글 내용 전체보기

FDA lets generics makers keep their legal shield, handing embattled industry a win

글 내용 전체보기

Teva to move global HQ to Tel Aviv amid $3B cost-cutting drive

글 내용 전체보기

EuroBiotech Report—Lilly-AC Immune, AstraZeneca, Circassia, Novo and Biofrontera

글 내용 전체보기